Document is current
Any future updates will be listed below
-
Authors
Suzuki, Jun-ichi
Shimamura, Munehisa
Suda, Hiroyuki
Wakayama, Kouji
Kumagai, Hidetoshi
Ikeda, Yuichi
Akazawa, Hiroshi
Isobe, Mitsuaki
Komuro, Issei
Morishita, Ryuichi
- License Information
-
More Information
Article History
Received: 18 August 2015
Revised: 18 October 2015
Accepted: 19 October 2015
First Online: 3 December 2015
Competing interests
: Ryuichi Morishita, who is a founder of AnGes MG and a stock-holder, has IP of HGF gene therapy drug. The other authors declare no conflict of interest.
Free to read: This content has been made available to all.
